Prognostic value of circulating tumor DNA in gastric cancer: a systematic review and meta-analysis with emphasis on postoperative molecular residual disease
Despite curative-intent surgery, recurrence remains a major cause of mortality in gastric cancer, while conventional clinicopathological staging provides limited accuracy for postoperative risk stratification. Circulating tumor DNA (ctDNA), a promising biomarker of molecular residual disease (MRD), has emerged as...